Specifically, we were interested in determining whether the CD271+ cells possessed the primary tumor initiating capacity among the CD44+ population and if the CD44+CD271+ cells represented the more specific TIC population in SCCHN. Here, NGFR is linked to head and neck squamous cell carcinoma.